Literature DB >> 15851375

Skin disorders in association with monoclonal gammopathies.

A Harati1, N H Brockmeyer, P Altmeyer, Alexander Kreuter.   

Abstract

Monoclonal gammopathy represents a condition characterized by clonal proliferation and accumulation of immunoglobulin producing B-cells. A variety of skin disorders are associated with an increased level of monoclonal immunoglobulin proteins. These skin disorders can be divided into two groups. The first group represents a direct consequence of plasma cell proliferation. The colonization of the plasma cell clone in the dermis expressed as a deposition of proteins related to the M component belongs to this group for which the pathogenesis is well identified, as is the case for example with AL amyloidosis and cryoglobulins. The second group represents skin disorders such as scleromyxedema and Schnitzler syndrome that are highly associated with an M component, or diseases such as pyoderma gangrenosum and leukocytoclastic vasculitis that are more weakly associated with increased levels of monoclonal immunoglobulins. In some other dermatoses such as pemphigus, bullous pemphigoid, epidermolysis bullosa aquisita, Sezary syndrome, lymphomatoid papulosis, urticaria pigmentosa, and acquired ichthyosis, only presumptions exist regarding associations with monoclonal gammopathies. In this the pathogenesis, therapy and prognosis of the most relevant dermatoses shall be described in order of their degree of association with monoclonal gammopathies, which shall also be discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15851375

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  4 in total

1.  IgA pemphigus associated with monoclonal gammopathy completely resolved after achievement of complete remission of multiple myeloma with bortezomib, cyclophosphamide and dexamethasone regimen.

Authors:  Zdenek Adam; Marta Krejcí; Ludek Pour; Josef Feit; Tomás Büchler; Roman Hájek
Journal:  Wien Klin Wochenschr       Date:  2010-05       Impact factor: 1.704

2.  Sunitinib induced pyoderma gangrenosum-like ulcerations.

Authors:  S Akanay-Diesel; N P Hoff; S Kürle; J Haes; A Erhardt; D Häussinger; K-W Schulte; Edwin Bölke; C Matuschek; W Budach; P A Gerber; B Homey
Journal:  Eur J Med Res       Date:  2011-11-10       Impact factor: 2.175

3.  Cutaneous Manifestations of Multiple Myeloma.

Authors:  Binodini Behera; Monali Pattnaik; Bharti Sahu; Prasenjeet Mohanty; Swapna Jena; Liza Mohapatra
Journal:  Indian J Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.494

4.  Pemphigus vulgaris as the first manifestation of multiple myeloma: a case report.

Authors:  Fandresena Arilala Sendrasoa; Irina Mamisoa Ranaivo; Mendrika Fifaliana Rakotoarisaona; Onivola Raharolahy; Naina Harinjara Razanakoto; Malalaniaina Andrianarison; Lala Soavina Ramarozatovo; Fahafahantsoa Rapelanoro Rabenja
Journal:  J Med Case Rep       Date:  2018-09-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.